These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 22994939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P, Jackson EK.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 7. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.
    Wu JN, Edwards D, Berecek KH.
    Hypertension; 1994 Jun; 23(6 Pt 2):819-22. PubMed ID: 8206610
    [Abstract] [Full Text] [Related]

  • 8. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 9. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S, Kato J, Kuwasako K, Asami M, Kitamura K.
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ, Blaschak CM, Chinoy MR, Jackson EK.
    Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ, Jackson EK.
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [Abstract] [Full Text] [Related]

  • 12. Exosome-Mediated Transfer of ACE (Angiotensin-Converting Enzyme) From Adventitial Fibroblasts of Spontaneously Hypertensive Rats Promotes Vascular Smooth Muscle Cell Migration.
    Tong Y, Ye C, Ren XS, Qiu Y, Zang YH, Xiong XQ, Wang JJ, Chen Q, Li YH, Kang YM, Zhu GQ.
    Hypertension; 2018 Oct; 72(4):881-888. PubMed ID: 30354715
    [Abstract] [Full Text] [Related]

  • 13. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat.
    Kost CK, Jackson EK.
    Hypertension; 1993 Apr; 21(4):420-31. PubMed ID: 8458644
    [Abstract] [Full Text] [Related]

  • 14. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
    Bohmann C, Rist W, Schollmeyer P, Rump LC.
    Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199
    [Abstract] [Full Text] [Related]

  • 15. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 16. Effect of low doses of angiotensin II perfusion on the hypotensive action of captopril in anaesthetized normotensive and spontaneously hypertensive rats.
    Staroukine MA, Giot JM, Verniory AE.
    J Hypertens; 1986 Feb; 4(1):27-33. PubMed ID: 3514745
    [Abstract] [Full Text] [Related]

  • 17. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
    Guzmán-Hernández EA, Villalobos-Molina R, Sánchez-Mendoza MA, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M.
    Can J Physiol Pharmacol; 2015 Apr; 93(4):299-308. PubMed ID: 25761067
    [Abstract] [Full Text] [Related]

  • 18. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
    Benter IF, Yousif MH, Al-Saleh FM, Raghupathy R, Chappell MC, Diz DI.
    J Cardiovasc Pharmacol; 2011 May; 57(5):559-67. PubMed ID: 21326110
    [Abstract] [Full Text] [Related]

  • 20. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K, Morishita R, Moriguchi A, Tomita N, Yo Y, Nishii T, Nakamura T, Higaki J, Ogihara T.
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.